Niche Calprotectin BDC offers the broadest calprotectin product range including fCAL and sCAL turbo, with patented CALEX sampling devices, presenting a strong cross-sell opportunity to labs requiring robust stool and serum calprotectin solutions.

Clinical and Research Reach As a North American affiliate of a global diagnostics leader, BDC can leverage established product lines (ELISA, ELISA-based calprotectin, flow cytometry, neurotransmitter panels) to target clinics, hospital labs, and academic research centers needing expanded assay portfolios.

Specialized Assay Portfolio BDC’s unique offerings in Cellular Allergy testing and Neuroimmunology (Flow CAST, GanglioCombi) plus chromobiology and niche clinical chemistry assays create opportunities to upsell to labs pursuing specialized diagnostic panels beyond routine tests.

Momentum and Launches Recent introduction of sCAL turbo signals ongoing product development and market expansion; sales teams can pursue labs upgrading from fCAL to turbo variants or integrating new serum calprotectin workflows.

Small but Strategic With a lean team and revenue in the lower mid-range, targeted outreach to mid-to-large academic medical centers and specialty clinics could yield high-margin partnerships by consolidating multiple BÜHLMANN lines under single procurement programs.